Crossmark

Evaluating the expression level of Survivin gene in different groups of B-cell acute lymphoblastic leukemia patients of Iran

Crossref DOI link: https://doi.org/10.1007/s11033-019-04703-z

Published Online: 2019-04-30

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohammadi, Mahan https://orcid.org/0000-0002-9170-9343
Amirmahani, Farzane https://orcid.org/0000-0002-4555-634X
Goharrizi, Kiarash Jamshidi https://orcid.org/0000-0002-5351-3577
Pakzad, Rambod https://orcid.org/0000-0002-5553-0768
Dolat, Hossein https://orcid.org/0000-0001-5763-5064
License Information

Text and Data Mining valid from 2019-04-30
More Information

Article History

Received: 13 November 2018

Accepted: 12 February 2019

First Online: 30 April 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This study is approved by Islamic Azad university of Ahar (Tabriz, Iran) review board and also the ethics committee of Children Medical Research and Training Hospital (Tabriz, Iran). A written consent form was obtained from each patient ҆s patent according to the Declaration of Helsinki.

: A written informed consent was also obtained from parents of healthy control subjects.